Search

Search Results
Results 4521 - 4530 of 5284 for Active site
  • From R&D to GMP: Advancing small molecules to phase I manufacturing
    White Paper - 7 May 2026
    Advancing small molecules from R&D to GMP requires coordinated strategies to support phase I clinical manufacturing.
  • Winrevair
    Drug - 7 May 2026
    Consumer Medicine Information (CMI) about Winrevair intended for persons living in Australia.
  • Continuous monitoring in pharmaceutical cleanrooms
    White Paper - 6 May 2026
    Continuous monitoring ensures contamination control and GMP compliance in pharmaceutical cleanrooms, supporting sterility and consistent product quality.
  • Malarone
    Drug - 5 May 2026
    Consumer Medicine Information (CMI) about Malarone intended for persons living in Australia.
  • Daonil
    Drug - 1 May 2026
    Consumer Medicine Information (CMI) about Daonil intended for persons living in Australia.
  • What are ESKAPE Pathogens and Why are They So Dangerous?
    Health - 30 Apr 2026
    As antibiotic resistance accelerates, ESKAPE pathogens reveal how hospital superbugs survive treatment, spread across environments, and challenge the future of infection control.
  • Lipid nanoparticles in drug delivery
    White Paper - 30 Apr 2026
    Lipid nanoparticles address key drug delivery challenges, including immune evasion, toxicity, and regulatory approval.
  • Tecentriq SC
    Drug - 30 Apr 2026
    Consumer Medicine Information (CMI) about Tecentriq SC intended for persons living in Australia.
  • How Engineered Biochar Improves Microplastic Removal
    Life Sciences - 29 Apr 2026
    As a multifunctional material, biochar traps microplastics and pollutants, enhancing environmental remediation and promoting sustainability in water treatment.
  • Testavan
    Drug - 24 Apr 2026
    Consumer Medicine Information (CMI) about Testavan intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback